ID   Granta-452
AC   CVCL_1817
SY   GRANTA-452; Granta 452; GRANTA 452
DR   BioSample; SAMN03473396
DR   cancercelllines; CVCL_1817
DR   Cosmic; 2297014
DR   DSMZ; ACC-713
DR   DSMZCellDive; ACC-713
DR   GEO; GSM119556
DR   Progenetix; CVCL_1817
DR   Wikidata; Q54871670
RX   PubMed=7849311;
RX   PubMed=16960149;
RX   PubMed=26727417;
CC   Doubling time: ~48 hours (DSMZ=ACC-713).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): DSMZ=ACC-713
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 13,16
ST   D19S433: 15
ST   D21S11: 28,31
ST   D2S1338: 19,25
ST   D3S1358: 16,17
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   D8S1179: 11
ST   FGA: 21,22
ST   Penta D: 13
ST   Penta E: 12,17
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
RX   PubMed=7849311; DOI=10.1182/blood.V85.4.893.bloodjournal854893;
RA   Stranks G., Height S.E., Mitchell P., Jadayel D.M., Yuille M.A.R.,
RA   De Lord C.F.M., Clutterbuck R.D., Treleaven J.G., Powles R.L.,
RA   Nacheva E., Oscier D.G., Karpas A., Lenoir G.M., Smith S.D.,
RA   Millar J.L., Catovsky D., Dyer M.J.S.;
RT   "Deletions and rearrangement of CDKN2 in lymphoid malignancy.";
RL   Blood 85:893-901(1995).
//
RX   PubMed=16960149; DOI=10.1182/blood-2006-06-026500;
RA   Mestre-Escorihuela C., Rubio-Moscardo F., Richter J.A., Siebert R.,
RA   Climent J., Fresquet V., Beltran E., Agirre X., Marugan I., Marin M.,
RA   Rosenwald A., Sugimoto K.-j., Wheat L.M., Karran E.L., Garcia J.F.,
RA   Sanchez-Verde L., Prosper F., Staudt L.M., Pinkel D., Dyer M.J.S.,
RA   Martinez-Climent J.A.;
RT   "Homozygous deletions localize novel tumor suppressor genes in B-cell
RT   lymphomas.";
RL   Blood 109:271-280(2007).
//
RX   PubMed=26727417; DOI=10.3109/10428194.2015.1108414;
RA   Drexler H.G., Eberth S., Nagel S., MacLeod R.A.F.;
RT   "Malignant hematopoietic cell lines: in vitro models for double-hit
RT   B-cell lymphomas.";
RL   Leuk. Lymphoma 57:1015-1020(2016).
//